Security key
230031106
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)
CUSIP: 230031106
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 61,676,366
- Total 13F shares
- 36,693,312
- Share change
- +4,483,983
- Total reported value
- $394,818,289
- Put/Call ratio
- 1139%
- Price per share
- $10.76
- Number of holders
- 102
- Value change
- +$48,696,476
- Number of buys
- 52
- Number of sells
- 56
Report period
Q2 2023
Institutions
102
Top holders
10
CGEM full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Cullinan Therapeutics, Inc. SEC filings
Cullinan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230031106
Recent filing periods:
Top shareholders of CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
12%
|
7,648,268
|
$78,241,782 | — | 31 Mar 2023 | |
| CHI Advisors LLC |
13F
|
Company |
5.4%
|
3,349,460
|
$34,264,977 | — | 31 Mar 2023 | |
| BVF INC/IL |
13F
|
Company |
5.2%
|
3,196,701
|
$32,702,251 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
2,554,988
|
$26,137,527 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.7%
|
2,255,597
|
$23,074,757 | — | 31 Mar 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
2%
|
1,236,349
|
$12,647,851 | — | 31 Mar 2023 | |
| Nextech Invest Ltd. |
13F
|
Company |
2%
|
1,221,145
|
$12,492,313 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
1,074,082
|
$10,988,000 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
789,138
|
$8,072,880 | — | 31 Mar 2023 | |
| Rubric Capital Management LP |
13F
|
Company |
1%
|
626,929
|
$6,413,484 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
623,068
|
$6,373,986 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.98%
|
605,387
|
$6,193,109 | — | 31 Mar 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.95%
|
584,942
|
$5,983,957 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.91%
|
562,214
|
$5,751,449 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
537,823
|
$5,501,929 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.81%
|
500,000
|
$5,115,000 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.56%
|
346,219
|
$3,541,820 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.52%
|
322,928
|
$3,293,866 | — | 31 Mar 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
265,032
|
$2,711,277 | — | 31 Mar 2023 | |
| Artal Group S.A. |
13F
|
Company |
0.41%
|
250,000
|
$2,558,000 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.4%
|
248,578
|
$2,542,953 | — | 31 Mar 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.4%
|
246,410
|
$2,520,774 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
244,553
|
$2,502,000 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.39%
|
239,200
|
$2,447,000 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.36%
|
221,340
|
$2,264,308 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
187,533
|
$1,918,463 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.29%
|
179,820
|
$1,839,558 | — | 31 Mar 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.28%
|
169,886
|
$1,737,934 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
165,948
|
$1,697,648 | — | 31 Mar 2023 | |
| Atom Investors LP |
13F
|
Company |
0.19%
|
120,109
|
$1,228,715 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
101,052
|
$1,033,761 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
96,240
|
$984,536 | — | 31 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
88,292
|
$903,227 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
86,201
|
$881,836 | — | 31 Mar 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.12%
|
75,000
|
$767,250 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.12%
|
73,572
|
$752,642 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
72,208
|
$739,000 | — | 31 Mar 2023 | |
| VIRGINIA RETIREMENT SYSTEMS ET Al |
13F
|
Company |
0.1%
|
61,900
|
$633,237 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.1%
|
59,832
|
$612,082 | — | 31 Mar 2023 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.09%
|
55,170
|
$5,393 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.09%
|
54,272
|
$555,203 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
51,093
|
$523,000 | — | 31 Mar 2023 | |
| Ergoteles LLC |
13F
|
Company |
0.08%
|
48,622
|
$497,403 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.07%
|
44,152
|
$452,000 | — | 31 Mar 2023 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.07%
|
43,905
|
$449,148 | — | 31 Mar 2023 | |
| MARTINGALE ASSET MANAGEMENT L P |
13F
|
Company |
0.07%
|
42,529
|
$435,072 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.06%
|
34,400
|
$351,912 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
32,700
|
$334,521 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
29,600
|
$302,808 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
28,313
|
$289,642 | — | 31 Mar 2023 |
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q2 2023
As of 30 Jun 2023,
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,693,312 shares.
The largest 10 holders included
BIOIMPACT CAPITAL LLC, CHI Advisors LLC, BVF INC/IL, FRANKLIN RESOURCES INC, BlackRock Inc., VANGUARD GROUP INC, BRAIDWELL LP, AMERICAN INTERNATIONAL GROUP, INC., Nextech Invest Ltd., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
102
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
97
Q2 2023 holders
102
Holder diff
5
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.